GCM
JNJ icon

Gabalex Capital Management’s Johnson & Johnson JNJ Stock Holding History

Gabalex Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-30,000
Closed -$4.84M – 18
2021
Q3 		$4.84M Hold
30,000
– – 2.24% 19
2021
Q2 		$4.94M Sell
30,000
-30,000
-50% -$4.97M 2.32% 19
2021
Q1 		$9.86M Buy
60,000
+12,973
+28% +$2.1M 4.98% 11
2020
Q4 		$7.4M Sell
47,027
-52,973
-53% -$7.82M 4.01% 13
2020
Q3 		$14.9M Buy
100,000
+5,000
+5% +$740K 4.17% 10
2020
Q2 		$13.4M Buy
+95,000
New +$13.8M 4.21% 10

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Gabalex Capital Management's JNJ Position: Q4 2021 in Review

Gabalex Capital Management sold out of Johnson & Johnson (JNJ) in Q4 2021, closing a stake of 30,000 shares — an estimated $4.84M sold.

Gabalex Capital Management first reported a position in JNJ in Q2 2020 and held it in 6 quarters. The position peaked at $14.9M in Q3 2020. 3,645 funds tracked by Wall St. Rank hold JNJ as of Q4 2021.

  • Gabalex Capital Management reported no remaining Johnson & Johnson position as of Q4 2021 after selling out during the quarter.
  • Gabalex Capital Management sold 30,000 Johnson & Johnson shares in Q4 2021, an estimated $4.84M.
  • Gabalex Capital Management first reported a position in Johnson & Johnson in Q2 2020 and held it in 6 quarters.
  • Gabalex Capital Management's Johnson & Johnson position peaked at $14.9M in Q3 2020.
  • 3,645 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2021.

Based on Gabalex Capital Management's 13F filing for Q4 2021, filed 2 Feb 2022.